Skip to main content

Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC

User login

Username

Password

Reset your password

Type	Lead	score